| Ms Nicole Lynne Albert, LPC | |
|
4056 Wetherburn Way, Suite 8, Norcross, GA 30092-4608 | |
| (770) 409-0005 | |
| Not Available |
| Full Name | Ms Nicole Lynne Albert |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 4056 Wetherburn Way, Norcross, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073819553 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | LPC002453 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Nicole Lynne Albert, LPC 4056 Wetherburn Way, Suite 8, Norcross, GA 30092-4608 Ph: (770) 409-0005 | Ms Nicole Lynne Albert, LPC 4056 Wetherburn Way, Suite 8, Norcross, GA 30092-4608 Ph: (770) 409-0005 |
News Archive
QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), announced today that it was issued U.S. Patent No. 7,625,942, a "Method of Treating Down Syndrome" by the U.S. Patent and Trademark Office. The '942 patent covers use of Posiphen and analogs to treat cognitive impairments associated with Down Syndrome (DS). This patent valuably expands upon the original Posiphen and analog patent that claims composition of matter and use of compounds to lower amyloid-β precursor protein (APP) and thereby treat dementia and Alzheimer's disease (AD).
Luitpold Pharmaceuticals, Inc. today announced that it has temporarily suspended distribution of all of its drug products manufactured at its Shirley, New York facility and marketed by its American Regent, Inc. subsidiary and Animal Health Division.
Researchers from University College London have devised a new way by which they could decipher the language cancer cells use to communicate among themselves. They found this unique method of communication between the cancer cells in organoids or collections of cells mimicking a mini organism in the lab.
CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today that the Company has submitted a Phase 2b clinical trial protocol, for its lead product candidate, PRO 140, to the U.S. Food and Drug Administration for treatment substitution in patients with Human Immunodeficiency Virus (HIV).
A study in this week's issue of THE LANCET describes how two different types of analysis used in conjunction on samples of tonsil tissue is the ‘gold standard' method for confirming clinical variant CJD
› Verified 5 days ago
Dr. Reginald B. Riley, PH.D. Counselor Medicare: Not Enrolled in Medicare Practice Location: 8000 Miller Ct E, Norcross, GA 30071 Phone: 770-734-8091 Fax: 770-734-8094 | |
Dr. Anthony S Lewis, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 5712 Pine Oak Dr, Norcross, GA 30092 Phone: 770-696-1549 | |
Tequila Olivia Banks, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 8303 Dunleaf Arc Way Nw, Norcross, GA 30093 Phone: 470-658-8156 | |
Mercianna R Oliver, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1780 Graves Rd Apt 514, Norcross, GA 30093 Phone: 404-493-3803 | |
Lan Chen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3200 Pointe Pkwy, Suite 400, Peachtree Corners, Norcross, GA 30092 Phone: 678-259-9298 | |
Kenanesha Owens, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3040 Holcolmb Bridge Rd Suite J2, Norcross, GA 30071 Phone: 770-696-9231 | |
Diana L Woodruff, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 4530 South Berkeley Lake Rd, Suite B, Norcross, GA 30071 Phone: 770-446-5642 Fax: 770-446-5643 |